Defecetive Drugs: adrugrecall.com
NEWSLETTER
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
A Drug Recall Newsletter July 2004 Newsletter
Want to stay on top of the most recent drug side effects and recall news? Have the latest Newsletter delivered straight to your inbox. Sign up Now!
Top Stories
Study finds conflict of interest affecting prominent medical journals
-July 13, 2004
A study by the consumer group Center for Science in the Public Interest has found that eight percent of the articles in four prominent medical journals were co-authored by researchers with undisclosed conflicts of interest. Medical and academic journals usually require authors to disclose financial ties to parties that might be benefiting from the research. The study's lead researcher thinks that there is a "distinct trend among some researchers to simply ignore the rules journals have put in place and journals have very few tools in place to catch this kind of thing." This study has been released at a time where corporate influence on medical research was already under the spotlight.
For more information on drug safety, please contact us.Top Stories
Jury acquits eight current or former TAP employees for bribery and paying kickbacks
-July 16, 2004
Eight current or former TAP Pharmaceutical Products employees have been acquitted of bribing and paying kickbacks to doctors in an attempt to win business for the drug maker. The employees were accused of offering ski trips, dinners, sporting event tickets, and free drug samples to doctors who would in turn prescribe its antacid drug Prevacid and prostate cancer drug Lupron.
Three years ago, the drug maker paid a record $885 million fine to settle similar allegations. Defendants continue to maintain innocence in what they classified to be confusing drug marketing rules.
For more information on drug safety, please contact us.
Top Stories
Antidepressant alerts issued by FDA
-July 19, 2004
The FDA has issued an alert, urging physicians to closely monitor adult and child patients using antidepressant drugs for signs of worsening depression or if thoughts of suicide are present. There have already been label changes for antidepressant drugs Wellbutrin, Zyban, Paxil and Serzone in response to the possible safety issues.
For more information on drug safety, please contact us.Baycol
Bayer to pay $1.06 billion to settle Baycol lawsuits
-July 13, 2004
Bayer has agreed to pay $1.06 billion to settle 2,771 Baycol lawsuits. There are still 8,048 Baycol cases pending, a decrease of 515 Baycol lawsuits from a month prior. Baycol was recalled in August 2001 after the cholesterol drug was linked to rhabdomyolysis and kidney failure. There are as many as 100 Baycol deaths that have been suffered.
For more information on the Baycol recall and Baycol lawsuits, please contact us.Crestor
Public Citizen charges Crestor consultant also top government researcher
-July 10, 2004
After Crestor was approved in August 2003, a top government researcher praised the cholesterol-reducing drug but never mentioned his ties as a consultant to the drug maker, according to charges by a watchdog group Public Citizen. 
read article ....
Crestor
Crestor maker asks FDA to disregard Public Citizen petition
-July 21, 2004
AstraZeneca responded to the March 4, 2004 petition submitted by consumer watchdog group Public Citizen requesting the FDA ban Crestor cholesterol-reducing drug. The drug company sent a 30-page response to the FDA, claiming Public Citizen's petition provides no scientific basis for challenging the FDA's conclusion of Crestor being a safe and effective drug therapy.
For more information on Crestor side effects, please contact us.
Lariam
Cowardice accusations dropped after Lariam imbalance blamed
-July 15, 2004
A case against Sgt. Pogany, initially accused of cowardice and later reduced to dereliction of duty, was finally dropped after nine months. Pogany was an interrogator with Special Forces when he suffered a panic attack after seeing a bloody Iraqi corpse on his second day in the war zone. read article ....
Meridia
Judge dismisses 113 Meridia lawsuits
-July 15, 2004
A federal judge has dismissed 113 Meridia cases after deciding there was an absence of sufficient evidence displaying Meridia harmed them. The plaintiffs had claimed severe Meridia side effects including heart attacks and birth defects were suffered. Abbott Laboratories still faces seven Meridia cases in state courts, and Public Citizen consumer group has petitioned the FDA to remove the anti-obesity medication from the market.
For more information on Meridia side effects, please contact us.
OxyContin
Experimental abuse-resistant form of OxyContin shows promise
-June 29, 2004
A biotechnology company has concluded a small human experiment that shows promise of an abuse-resistant form of OxyContin. OxyContin has annual sales of $1.7 billion, the most popular form of oxycodone. The time release pill is intended for chronic pain, but over the years users have discovered crushing the tablets and snorting, ingesting or injecting the powder can create an immediate, heroin-like high. So far, hundreds of OxyContin deaths because of overdose have occurred, shifting the focus on ways to prevent the widespread abuse from continuing to occur.
For more information on Oxycontin side effects, please contact us.
Paxil
Paxil patients left unhappier after beginning drug therapy
-July 11, 2004
There are about 4,000 Paxil patients involved in a class action lawsuit against Paxil maker GlaxoSmithKline, with allegations that they should have received warnings of the dangers and addiction Paxil can cause. read article ....
Rezulin
Rezulin lawsuit settled
-July 2, 2004
Pfizer has reached an agreement to settle a statewide Rezulin class action lawsuit in Illinois. Rezulin diabetes drug was introduced in the late 90s and pulled off the market by 2000 after being linked to fatal liver failure. Pfizer said a $60 million settlement fund would be created to finance diabetes research and to document expenses associated with treating the disease.
For more information on Rezulin lawsuits, please contact us.
Thimerosal
Government wants babies immunized against the flu, causing new autism scare
-July 19, 2004
The debate over thimerosal containing vaccines and the dramatic rise in autism cases alongside increases in required and recommended vaccines has caused heated discussions for years. read article ....
Zoloft
Zoloft for alcoholism may be more detrimental
-July 14, 2004
Zoloft is an SSRI antidepressant drug that is often used to help relieve depression that accompanies alcoholism. A new study shows that Zoloft for treating type B alcoholics has no beneficial effect and may even cause increased drinking. read article ....
For more information on Zoloft, please contact us.
